Current diagnosis and management of peripheral tuberculous Lymphadenitis

Clinical Infectious Diseases

Volumn 53, Issue 6, 2011, Pages 555-562

  Fontanilla, Jose Mario ^a   Barnes, Arti ^b   Von Reyn, C Fordham ^c  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ACID FAST BACTERIUM; ANTIBIOTIC THERAPY; ASPIRATION BIOPSY; BACTERIUM CULTURE; CERVICAL LYMPH NODE; CLINICAL FEATURE; DIAGNOSTIC TEST; EXCISION; GRANULOMATOUS INFLAMMATION; GROUPS BY AGE; HUMAN; IMMUNOCOMPROMISED PATIENT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PARADOXICAL DRUG REACTION; PARADOXICAL UPGRADING REACTION; PRIORITY JOURNAL; REVIEW; SEX RATIO; SWELLING; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

ADULT; ANTITUBERCULAR AGENTS; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; UNITED STATES;

EID: 80052211957     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir454     Document Type: Review

References (64)

1. CDC. Reported tuberculosis in the United States, 2008. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2009. September 2009.
2. Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis 1992; 15:601-5.
3. Artenstein AW, Kim JH, Williams WJ, Chung RC. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995; 20:876-82.
4. Gonzalez OY, Teeter LD, Thanh BT, Musser JM, Graviss EA. Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: a population-based analysis in Houston, Texas, USA. Int J Tuberc Lung Dis 2003; 7:987-93. (Pubitemid 37237063)
5. Polesky A, Grove W, Bhatia G. Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore) 2005; 84:350-62. (Pubitemid 41668934)
6. Rock RB, Sutherland WM, Baker C, Williams DN. Extrapulmonary tuberculosis among Somalis in Minnesota. Emerg Infect Dis 2006; 12:1434-6. (Pubitemid 44455224)
7. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49:1350-7.
8. Wark P, Goldberg H, Ferson M, McKenzie D, Lau E, Rivas K. Mycobacterial lymphadenitis in eastern Sydney. Aust N Z J Med 1998; 28:453-8. (Pubitemid 28410771)
9. Fain O, Lortholary O, Djouab M, et al. Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virus. Int J Tuberc Lung Dis 1999; 3:162-5. (Pubitemid 29151822)
10. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest 2002; 121:1177-82. (Pubitemid 34280440)
11. Menon K, Bem C, Gouldesbrough D, Strachan DR. A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UK. J Laryngol Otol 2007; 121:362-8. (Pubitemid 46714679)
12. Asimacopoulos EP, Berry M, Garfield B, et al. The diagnostic efficacy of fine-needle aspiration using cytology and culture in tuberculous lymphadenitis. Int J Tuberc Lung Dis 2010; 14:93-8.
13. Chen YM, Lee PY, Su WJ, Perng RP. Lymph node tuberculosis: 7-year experience in Veterans General hospital, Taipei, Taiwan. Tubercle Lung Dis 1992; 73:368-71.
14. Bem C. Human immunodeficiency virus-positive tuberculous lymphadenitis in Central Africa: clinical presentation of 157 cases. Int J Tuberc Lung Dis 1997; 1:215-9. (Pubitemid 127509650)
15. Wei YF, Liaw YS, Ku SC, Chang YL, Yang PC. Clinical features and predictors of a complicated treatment course in peripheral tuberculous lymphadenitis. J Formos Med Assoc 2008; 107:225-31.
16. Khan R, Harris SH, Verma AK, Syed A. Cervical lymphadenopathy: scrofula revisited. J Laryngol Otol 2009; 123:764-7.
17. Khan FY. Clinical pattern of tuberculous adenitis in Qatar: experience with 35 patients. Scand J Infect Dis 2009; 41:128-34.
18. Kong Y, Cave MD, Zhang L, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol 2007; 45:409-14.
19. Hesseling AC, Marais BJ, Kirchner HL, et al. Mycobacterial genotype is associated with disease phenotype in children. Int J Tuberc Lung Dis 2010; 14:1252-8.
20. Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 2004; 10:388-98. (Pubitemid 38714564)
21. Lee PP, Chan KW, Jiang L, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 2008; 27:224-30.
22. Kazwala RR, Daborn CJ, Sharp JM, Kambarage DM, Jiwa SF, Mbembati NA. Isolation of Mycobacterium bovis from human cases of cervical adenitis in Tanzania: a cause for concern? Int J Tuberc Lung Dis 2001; 5:87-91. (Pubitemid 32401881)
23. Yates MD, Grange JM. Bacteriological survey of tuberculous lymphadenitis in southeast England, 1981-1989. J Epidemiol Community Health 1992; 46:332-5.
24. Purohit MR, Mustafa T, Morkve O, Sviland L. Gender differences in the clinical diagnosis of tuberculous lymphadenitis-a hospital-based study from Central India. Int J Infect Dis 2009; 13:600-5.
25. Penfold CN, Revington PJ. A review of 23 patients with tuberculosis of the head and neck. Br J Oral Maxillofac Surg 1996; 34:508-10. (Pubitemid 26421251)
26. Prasad KC, Sreedharan S, Chakravarthy Y, Prasad SC. Tuberculosis in the head and neck: experience in India. J Laryngol Otol 2007; 121:979-85. (Pubitemid 351650447)
27. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70:384-97.
28. Lee KC, Tami TA, Lalwani AK, Schecter G. Contemporary management of cervical tuberculosis. Laryngoscope 1992; 102:60-4.
29. Ellison E, Lapuerta P, Martin SE. Fine needle aspiration diagnosis of mycobacterial lymphadenitis. Sensitivity and predictive value in the United States. Acta Cytol 1999; 43:153-7. (Pubitemid 29144707)
30. Singh KK, Muralidhar M, Kumar A, et al. Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol 2000; 53:355-61. (Pubitemid 30256903)
31. Blaikley JF, Khalid S, Ormerod LP. Management of peripheral lymph node tuberculosis in routine practice: an unselected 10-year cohort. Int J Tuberc Lung Dis 2011; 15:375-8.
32. Lau SK, Wei WI, Hsu C, Engzell UC. Efficacy of fine needle aspiration cytology in the diagnosis of tuberculous cervical lymphadenopathy. J Laryngol Otol 1990; 104:24-7. (Pubitemid 20046081)
33. Wright CA, van der Burg M, Geiger D, Noordzij JG, Burgess SM, Marais BJ. Diagnosing mycobacterial lymphadenitis in children using fine needle aspiration biopsy: cytomorphology, ZN staining and autofluorescence-making more of less. Diagn Cytopathol 2008; 36:245-51. (Pubitemid 351458183)
34. van Wyk AC, Marais BJ, Warren RM, van Wyk SS, Wright CA. The use of light-emitting diode fluorescence to diagnose mycobacterial lymphadenitis in fine-needle aspirates from children. Int J Tuberc Lung Dis 2011; 15:56-60.
35. Daley P, Thomas S, Pai M. Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis 2007; 11:1166-76. (Pubitemid 350146296)
36. Hillemann D, Ruesch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by automated GeneXpert(R) MTB/RIF system. J Clin Microbiol 2011; 49:1202-5.
37. Song KH, Jeon JH, Park WB, et al. Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis. Diagn Microbiol Infect Dis 2009; 63:182-7.
38. von Reyn CF,Williams DE,Horsburgh CR Jr, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177:730-6. (Pubitemid 28099890)
39. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4:761-76.
40. Ying M, Ahuja AT, Evans R, King W, Metreweli C. Cervical lymphadenopathy: sonographic differentiation between tuberculous nodes and nodal metastases from non-head and neck carcinomas. J Clin Ultrasound 1998; 26:383-9. (Pubitemid 28440619)
41. Yang ZG, Min PQ, Sone S, et al. Tuberculosis versus lymphomas in the abdominal lymph nodes: evaluation with contrast-enhanced CT. AJR Am J Roentgenol 1999; 172:619-23. (Pubitemid 29102115)
42. Romanus V, Hallander HO,Wahlen P, Olinder-Nielsen AM,Magnusson PH, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tubercle Lung Dis 1995; 76:300-10.
43. Panesar J, Higgins K, Daya H, Forte V, Allen U. Nontuberculous mycobacterial cervical adenitis: a ten-year retrospective review. Laryngoscope 2003; 113:149-54. (Pubitemid 36050531)
44. Treatment of tuberculosis. Centers for Disease Control. MMWR Recomm Rep 2003; 52:1-77.
45. Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993; 87:621-3. (Pubitemid 23350171)
46. Yuen AP, Wong SH, Tam CM, Chan SL, Wei WI, Lau SK. Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngol Head Neck Surg 1997; 116:189-92. (Pubitemid 27097543)
47. van Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL. Shortening the duration of treatment for cervical tuberculous lymphadenitis. Eur Respir J 2000; 15:192-5. (Pubitemid 30068960)
48. Nemir RL, Cardona J, Vaziri F, Toledo R. Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation. Am Rev Respir Dis 1967; 95:402-10.
49. Cho OH, Park KH, Kim T, et al. Paradoxical responses in non-HIVinfected patients with peripheral lymph node tuberculosis. J Infect 2009; 59:56-61.
50. Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 2005; 40:1368-71. (Pubitemid 40570251)
51. Wallis RS. Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 2005; 41:201-8. (Pubitemid 40962501)
52. Garcia Vidal C, Garau J. Systemic steroid treatment of paradoxical upgrading reaction in patients with lymph node tuberculosis. Clin Infect Dis 2005; 41:915-6; author reply 6-7.
53. Park KH, Cho OH, Chong YP, et al. Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis. J Infect 2010; 61:430-4.
54. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158:157-61. (Pubitemid 28337174)
55. Haddow LJ, Easterbrook PJ, Mosam A, et al. Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis 2009; 49:1424-32.
56. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39:1709-12. (Pubitemid 39578550)
57. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001; 120:193-7. (Pubitemid 32744878)
58. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21:335-41. (Pubitemid 46175045)
59. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994; 19:1092-9. (Pubitemid 24380024)
60. Iles PB, Emerson PA. Tuberculous lymphadenitis. Br Med J 1974; 1:143-5.
61. Ammari FF, Bani Hani AH, Ghariebeh KI. Tuberculosis of the lymph glands of the neck: a limited role for surgery. Otolaryngol Head Neck Surg 2003; 128:576-80. (Pubitemid 36438436)
62. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007; 44:1057-64. (Pubitemid 46580272)
63. Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, Samra Z, Kaufman L, Amir J. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J 2008; 27:920-2.
64. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.